Topical Metronidazole Versus Ivermectin for Low-density Demodex Rosacea: A Rater-blinded, Randomized, Split-face Trial
- PMID: 36317858
- PMCID: PMC9811289
- DOI: 10.2340/actadv.v102.4391
Topical Metronidazole Versus Ivermectin for Low-density Demodex Rosacea: A Rater-blinded, Randomized, Split-face Trial
Conflict of interest statement
References
-
- Huang HP, Hsu CK, Lee JY. Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol. Dermatol Ther 2021; 34: e14899. - PubMed
-
- Huang HP, Hsu CK, Lee JY. Thumbnail-squeezing method: an effective method for assessing Demodex density in rosacea. J Eur Acad Dermatol Venereol. 2020; 34: e343–e345. - PubMed
-
- Aşkin U, Seçkin D. Comparison of the two techniques for measurement of the density of Demodex folliculorum: standardized skin surface biopsy and direct microscopic examination. Br J Dermatol 2010; 162: 1124–1126. - PubMed
-
- Kawata AK, Revicki DA, Thakkar R, Jiang P, Krause S, Davidson MH, et al. . Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy. Clin Drug Investig 2009; 29: 215–229. - PubMed
-
- Ventre E, Rozières A, Lenief V, Albert F, Rossio P, Laoubi L, et al. . Topical ivermectin improves allergic skin inflammation. Allergy 2017; 72: 1212–1221. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
